Avicanna Inc. (AVCN.TO) Financials

AVCN.TO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 21.2 million 9.5 million
June 30, 2025 20.5 million 9.6 million
March 31, 2025 20.7 million 9.9 million
Dec. 31, 2024 20.1 million 10.4 million

AVCN.TO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -865192 433365
June 30, 2025 -215276 174770
March 31, 2025 -157710 207308
Dec. 31, 2024 -548009 214245

AVCN.TO Net Income

No data available :(

AVCN.TO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 464848 - -
June 30, 2025 207639 - 37095
March 31, 2025 456759 - 73500
Dec. 31, 2024 448028 - 109227

AVCN.TO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 114.6 million
June 30, 2025 112.1 million
March 31, 2025 110.4 million
Dec. 31, 2024 110.2 million

AVCN.TO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 22670 32097 4.3 million 867608
June 30, 2025 85300 116536 3.5 million 732644
March 31, 2025 140025 51072 3.3 million 787888
Dec. 31, 2024 307136 5943 4.3 million 713925

AVCN.TO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 6.4 million 3.2 million
June 30, 2025 6.2 million 3.0 million
March 31, 2025 6.3 million 2.7 million
Dec. 31, 2024 6.6 million 3.2 million

AVCN.TO

Price: CA$0.12

52 week price:
0.12
0.39

Earnings Per Share: -0.01 CAD

Exchange: TOR

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 18.8 million

Links: